CYP4V2 and metabolic syndrome: This important observation was further supported by evidence in Cyp4v3 (mouse ortholog) knockout mice (Cyp4v3−/−) and patients with mutations in CYP4V2 (human ortholog) where a systemic dyslipidemia and a decreased metabolism of labeled fatty acid were detected [68].